ICD-10-CM Billable Code

E23.1

Drug-induced hypopituitarism

Clinical Classification Guidelines

Use Additional Code

  • code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)

Medical Intelligence & Overview

Drug-induced hypopituitarism is a condition where the normal function of the pituitary gland is compromised due to adverse effects of certain medications. The pituitary gland, often called the master gland, plays a vital role in regulating various hormones essential for growth, metabolism, and reproduction. When this gland's activity diminishes because of drug effects, it can lead to a range of hormonal imbalances, impacting overall health and well-being.

Causes & Symptoms

Clinical Causes: Long-term use of medications that suppress pituitary function, such as high-dose corticosteroids. Use of certain chemotherapeutic agents or radiation therapy affecting the pituitary gland. Medications that interfere with hormone production or release, including some antidepressants and antipsychotics. Drug interactions resulting in hormonal suppression or disruption of the hypothalamic-pituitary axis. Overuse of hormonal therapies leading to feedback inhibition of the natural hormone production.

Key Symptoms: Fatigue and weakness Low blood pressure Decreased libido or sexual dysfunction Unexplained weight changes Cold intolerance and dry skin Loss of pubic or axillary hair Irregular or absent menstrual periods Growth retardation in children or adolescents Symptoms related to specific hormonal deficiencies, such as hypothyroidism or adrenal insufficiency

Diagnostic & Treatment

Diagnosis Path: The diagnosis of drug-induced hypopituitarism involves a combination of medical history, medications review, and blood tests. Diagnosing physicians typically order a series of hormone level assessments to evaluate the function of the pituitary gland and its target organs. Imaging studies, like MRI, may be conducted to rule out structural abnormalities or other causes. It is crucial to identify the specific medication contributing to hormone suppression and consider the duration and dosage involved.

Treatment Protocols: Treatment strategies focus on managing hormonal deficiencies and adjusting the use of causative medications when possible. These may include hormone replacement therapy for affected hormones, such as cortisol, thyroid hormones, or sex steroids. In cases where medication discontinuation or dose reduction is feasible, this approach can help restore hormonal balance. Close monitoring of hormone levels and symptoms is essential to ensure effective management and to minimize complications.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is E23.1 a billable ICD-10 code?
Yes, E23.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report E23.1?
Clinical documentation must specify the nature of Drug-induced hypopituitarism and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes

Clinical Meta Tags

hypopituitarism